neostigmine has been researched along with Gall Bladder Diseases in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STALPORT, J | 1 |
| Melchionda, N | 1 |
| Benefenati, F | 1 |
2 other studies available for neostigmine and Gall Bladder Diseases
| Article | Year |
|---|---|
A SENSITIVE METHOD FOR FUNCTIONAL EXPLORATION OF THE ODDI'S SPHINCTER.
Topics: Ampulla of Vater; Atropine; Carbachol; Dogs; Epinephrine; Ergotamine; Gallbladder Diseases; Isoprote | 1964 |
[Mathematical formulation of gastrointestinal electromanometric tracings. I. Analysis of the correlation between some parameters of duodenal motility].
Topics: Acetylcholine; Amides; Benzoates; Cholecystokinin; Digestive System; Digestive System Physiological | 1968 |